Drug Shortage Report for MANNITOL INJECTION, USP
| Report ID | 162159 |
| Drug Identification Number | 02243176 |
| Brand name | MANNITOL INJECTION, USP |
| Common or Proper name | MANNITOL INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MANNITOL |
| Strength(s) | 25% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50mL |
| ATC code | B05BC |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-02 |
| Estimated end date | 2022-10-12 |
| Actual end date | 2022-10-12 |
| Shortage status | Resolved |
| Updated date | 2022-10-13 |
| Company comments | On 100% allocation until September 30, 2022. We will be encountering a supply interruption on our Mannitol Injection 250 mg/mL SD Vial 50 mL effective October 1, 2022 until October 12, 2022. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-10-13 | English | Compare |
| v6 | 2022-10-02 | French | Compare |
| v5 | 2022-10-02 | English | Compare |
| v4 | 2022-09-01 | French | Compare |
| v3 | 2022-09-01 | English | Compare |
| v2 | 2022-06-08 | French | Compare |
| v1 | 2022-06-08 | English | Compare |
Showing 1 to 7 of 7